ALKBH5 and hepatoblastoma: However, significant relationships between YTHDC1 rs2293596 T>C and ALKBH5 rs8400 G>A polymorphism and hepatoblastoma risk were observed in the subgroup of clinical stage III+IV in stratification analysis (118, 119), requiring further study to identify whether these SNPs correlate to the prognosis of hepatoblastoma.